Molecular Magnetic Resonance Imaging (mMRI).

Area of Science:

• Biomedical Imaging
• Nanotechnology
• Biochemistry

Background:

• Molecular magnetic resonance imaging (mMRI) allows in vivo protein detection.
• Contrast agents typically comprise a contrastophore and a pharmacophore.
• Enhanced sensitivity in mMRI is crucial for detecting low-abundance targets.

Purpose of the Study:

• To describe the production of targeted micro-sized particles of iron oxide (MPIO).
• To present MRI protocols for in vivo MPIO detection.
• To advance the sensitivity of molecular magnetic resonance imaging.

Main Methods:

• Utilized commercially available reagents for MPIO synthesis.
• Developed specific MRI protocols for MPIO detection.
• Employed a contrast-sensitive MRI sequence for imaging.

Main Results:

• Successfully produced targeted MPIO constructs.
• Demonstrated in vivo detection of MPIO using established MRI protocols.
• Achieved a significant increase in mMRI sensitivity due to MPIO payload.

Conclusions:

• Targeted MPIO production is feasible using standard reagents.
• The described methods enable sensitive in vivo detection of MPIO.
• This approach significantly enhances the capabilities of molecular magnetic resonance imaging.